Moreover, DDX5 significantly increased E2F1-mediated cell death to approximately 45%, indicating that DDX5 can also enhance E2F1-induced apoptosis, independent of p53, in cancer cells (Figure 6C). This evidence concerns the gene TP53 and cancer.